Isaralgagene civaparvovec is a “potential best-in-class gene therapy for Fabry disease,” according to analysts at H.C.

CDOs have become trusted data gurus, driving significant advancements in data maturity within their organizations.

Vast Data Inc. today announced enhancements to its Vast Data Platform, enabling it to support structured and unstructured data in a single DataSpace with linear and secure scaling.The enhancement ...

The MOD function in Excel is a highly versatile yet often underutilized tool that can simplify calculations and improve data management. By calculating remainders after division, it provides ...

“Additionally, we are working towards creating a robust data analytics ecosystem to support our supervisory functions, ensuring that our approach remains forward-looking and agile in a rapidly ...

Numerous cases and case series presented at EULAR 2024 add to a rapidly growing collection of evidence that CAR T-cell therapy will be a meaningful option in SLE and other rheumatic diseases.

Favorable long-term data of tocilizumab date back to 2009, when the STREAM study showed improved efficacy and safety for up to 5 years in patients with active disease.

When working with a large data set, you would be more productive if you knew how to quickly find what you need. Luckily, ...

Data to support Accelerated Approval pathway expected in first half of 2025, with potential Biologics License Application (BLA) submission to the U.S. Food and Drug Administration (FDA ...